{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T06:12:50Z","timestamp":1740809570959,"version":"3.38.0"},"reference-count":41,"publisher":"Japanese Society of Radiological Technology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Hoshasen Gijutsu Gakkai Zasshi","Jpn. J. Radiol. Technol."],"published-print":{"date-parts":[[2025]]},"DOI":"10.6009\/jjrt.25-1531","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:18:09Z","timestamp":1740694689000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Exposure Dose Reduction Effect for Cone-beam Computed Tomography with Bismuth Sheet in Image-guided Radiation Therapy of Prostate Cancer","\u524d\u7acb\u817a\u304c\u3093\u306e\u753b\u50cf\u8a98\u5c0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u30b3\u30fc\u30f3\u30d3\u30fc\u30e0CT\u306b\u30d3\u30b9\u30de\u30b9\u30b7\u30fc\u30c8\u3092\u4f7f\u7528\u3057\u305f\u6642\u306e\u88ab\u3070\u304f\u7dda\u91cf\u4f4e\u6e1b\u52b9\u679c\u306e\u8a55\u4fa1"],"prefix":"10.6009","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1311-4814","authenticated-orcid":false,"given":"Tatsuya","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Radiology, Koritsu Tatebayashi Kosei General Hospital"},{"name":"Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Graduate School of Radiological Technology, Gunma Prefectural College of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Koritsu Tatebayashi Kosei General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kawadai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Koritsu Tatebayashi Kosei General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Shibasaki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Koritsu Tatebayashi Kosei General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Nippon Medical School Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4040","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1\uff09\u2003Vlachaki MT, Teslow TN, Amosson C, et al. IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization. Med Dosim 2005; 30: 69\u201375.","DOI":"10.1016\/j.meddos.2005.01.002"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2\uff09\u2003Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72:          996\u20131001.","DOI":"10.1016\/j.ijrobp.2008.02.047"},{"key":"3","unstructured":"3\uff09\u2003Hegazy MW, Mostafa E, Nawar N. Which dosimetric technique is better; 3D-CRT, IMRT or VMAT in high risk prostate cancer treated by hypofractionated radiotherapy with elective nodal irradiation. SECI Oncol. J. 2023; 11: 194\u2013199."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4\uff09\u2003Soda R, Hatanaka S, Hariu M, et al. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study. J XRay Sci Technol 2020; 28: 243\u2013254.","DOI":"10.3233\/XST-190598"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5\uff09\u2003de Crevoisier R, Bayar MA, Pommier P, et al. Daily versus weekly prostate cancer image guided radiation therapy: Phase 3 multicenter randomized trial. Int J Radiat Oncol Biol Phys 2018; 102: 1420\u20131429.","DOI":"10.1016\/j.ijrobp.2018.07.2006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6\uff09\u2003Klaff R, Rosell J, Varenhorst E, et al. The long-term disease-specific mortality of low-risk localized prostate cancer: a prospective population-based register study over two decades. Urology 2016; 91: 77\u201382.","DOI":"10.1016\/j.urology.2016.01.033"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7\uff09\u2003Hamdy FC, Donovan JL, Lane LA, et al. Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2023; 388: 1547\u20131558.","DOI":"10.1016\/j.eururo.2023.08.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8\uff09\u2003Hayashi N, Osaka K, Muraoka K, et al. Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis. World J Urol 2020; 38: 2477\u20132484.","DOI":"10.1007\/s00345-019-03056-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9\uff09\u2003Perks JR, Lehmann J, Chen AM, et al. Comparison of peripheral dose from image-guided radiation therapy (IGRT) using kV cone beam CT to intensity-modulated radiation therapy (IMRT). Radiother Oncol 2008; 89: 304\u2013310.","DOI":"10.1016\/j.radonc.2008.07.026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10\uff09\u2003Kan MWK, Leung LHT, Wong W, et al. Radiation dose from cone beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2008; 70: 272\u2013279.","DOI":"10.1016\/j.ijrobp.2007.08.062"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11\uff09\u2003Bostrom PJ, Soloway MS. Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? Eur Urol 2007; 52: 973\u2013982.","DOI":"10.1016\/j.eururo.2007.07.002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12\uff09\u2003Fontenot JD, Lee AK, Newhauser WD. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys 2009; 74: 616\u2013622.","DOI":"10.1016\/j.ijrobp.2009.01.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13\uff09\u2003Murray LJ, Thompson CM, Lilley J, et al. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy          (VMAT) and flattening filter free (FFF) radiotherapy. Phys Med Biol 2015; 60: 1237\u20131257.","DOI":"10.1088\/0031-9155\/60\/3\/1237"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14\uff09\u2003Zhao S, Xie O, Yang R, et al. High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis. Cancer Manag Res 2019; 11: 587\u2013598.","DOI":"10.2147\/CMAR.S185867"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15\uff09\u2003Buwenge M, Scirocco E, Deodato F, et al. Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors. BMC Cancer 2020; 20: 90.","DOI":"10.1186\/s12885-020-6581-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16\uff09\u2003Stewart FA, Akleyev AV, Hauer-Jensen M, et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs-threshold doses for tissue reactions in a radiation protection context.          Ann ICRP 2012; 41: 1\u2013322.","DOI":"10.1016\/j.icrp.2012.02.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17\uff09\u2003Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27: 927\u2013943.","DOI":"10.1016\/S0889-8529(05)70048-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18\uff09\u2003Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005; 34: 12\u201317.","DOI":"10.1093\/jncimonographs\/lgi003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19\uff09\u2003Deng J, Chen Z, Nath R. Impact of kilo-voltage cone beam computed tomography on image-guided radiotherapy of prostate cancer. WC 2009. IFMBE Proc 2009; 25: 17\u201320.","DOI":"10.1007\/978-3-642-03474-9_5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20\uff09\u2003Deng J, Chen Z, Yu JB, et al. Testicular doses in image-guided radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2012; 82: e39\u2013e47.","DOI":"10.1016\/j.ijrobp.2011.01.071"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21\uff09\u2003Ding GX, Munro P, Pawlowski J, et al. Reducing radiation exposure to patients from kV-CBCT imaging. Radiother Oncol 2010; 97: 585\u2013592.","DOI":"10.1016\/j.radonc.2010.08.005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22\uff09\u2003Lawrence S, Seeram E. The current use and effectiveness of bismuth shielding in computed tomography: a systematic review. Open J Radiol 2017; 2: 7\u201316.","DOI":"10.17140\/ROJ-2-113"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23\uff09\u2003Mehnati P, Malekzadeh R, Sooteh MY. Use of bismuth shield for protection of superficial radiosensitive organs in patients undergoing computed tomography: a literature review and meta-analysis. Radiol Phys Technol 2019; 12: 6\u201325.","DOI":"10.1007\/s12194-019-00500-2"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24\uff09\u2003Fricke BL, Donnelly LF, Frush DP, et al. In-Plane bismuth breast shields for pediatric CT: effects on radiation dose and image quality using experimental and clinical data. AJR Am J Roentgenol 2003; 180: 407\u2013411.","DOI":"10.2214\/ajr.180.2.1800407"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25\uff09\u2003Einstein AJ, Elliston CD, Groves DW, et al. Effect of bismuth breast shielding on radiation dose and image quality in coronary CT angiography. J Nucl Cardiol 2012; 19: 100\u2013108.","DOI":"10.1007\/s12350-011-9473-x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26\uff09\u2003Alonso TC, Mour\u00e3o AP, Santana PC, et al. Assessment of breast absorbed doses during thoracic computed tomography scan to evaluate the effectiveness of bismuth shielding. Appl Radiat Isot 2016; 117: 55\u201357.","DOI":"10.1016\/j.apradiso.2016.03.018"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27\uff09\u2003Sung J, Baek TS, Yoon M, et al. Estimate of the shielding effect on secondary cancer risk due to cone-beam CT in image-guided radiotherapy. J Korean Phys Soc 2014; 65: 757\u2013762.","DOI":"10.3938\/jkps.65.757"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28\uff09\u2003Shimizu H, Sasaki K, Aoyama T, et al. Evaluation of a new acrylic-lead shielding device for peripheral dose reduction during cone-beam computed tomography. BJR Open 2022; 4: 20220043.","DOI":"10.1259\/bjro.20220043"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29\uff09\u2003Deng J, Chen Z, Roberts KB, et al. Kilovoltage imaging doses in the radiotherapy of pediatric cancer patients. Int J Radiat Oncol Biol Phys 2012; 82: 1680\u20131688.","DOI":"10.1016\/j.ijrobp.2011.01.062"},{"key":"30","unstructured":"30\uff09\u2003\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\uff0e\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u86cd\u5149\u30ac\u30e9\u30b9\u7dda\u91cf\u8a08\u7269\u7406\u6280\u8853\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\uff0e\u65e5\u672c\u533b\u5b66\u7269\u7406\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2022."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31\uff09\u2003Fan S, Yu C, He D, et al. Gamma rays induced defect centers in phosphate glass for radio-photoluminescence dosimeter. Radiat Meas 2011; 46: 46\u201350.","DOI":"10.1016\/j.radmeas.2010.09.002"},{"key":"32","unstructured":"32\uff09\u2003Joint Committee for Guides in Metrology. Evaluation of measurement data-guide to the expression of uncertainty in measurement. JCGM 100, 2008."},{"key":"33","unstructured":"33\uff09\u2003AGC\u30c6\u30af\u30ce\u30b0\u30e9\u30b9\u682a\u5f0f\u4f1a\u793e\uff0e\u86cd\u5149\u30ac\u30e9\u30b9\u7dda\u91cf\u8a08\u30fb\u5c0f\u578b\u7d20\u5b50\u30b7\u30b9\u30c6\u30e0DoseAce\u57fa\u672c\u7279\u6027\u8cc7\u6599\uff0eAGC\u30c6\u30af\u30ce\u30b0\u30e9\u30b9\u682a\u5f0f\u4f1a\u793e\uff0c\u9759\u5ca1\uff0c2014."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34\uff09\u2003Nelson AP, Ding GX. An alternative approach to account for patient organ doses from imaging guidance procedures. Radiother Oncol 2014; 112: 112\u2013118.","DOI":"10.1016\/j.radonc.2014.05.019"},{"key":"35","unstructured":"35\uff09\u2003Fryar CD, Carroll MD, Gu Q, et al. Anthropometric reference data for children and adults: United States, 2015-2018. Vital Health Stat 3 2021; 36: 1\u201344."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36\uff09\u2003Hopper KD, King SH, Lobell ME, et al. The breast: in-plane x-ray protection during diagnostic thoracic CT--shielding with bismuth radioprotective garments. Radiology 1997; 205: 853\u2013858.","DOI":"10.1148\/radiology.205.3.9393547"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37\uff09\u2003Kosaka H, Tamura M, Hattori S, et al. Reduction of the computed tomography dose to the gonads of adolescent and young adult males through use of a tungsten-containing rubber sheet. Radiat Prot Dosimetry 2023; 199: 366\u2013372.","DOI":"10.1093\/rpd\/ncac295"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38\uff09\u2003Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group\/American college          of radiology 95-09. J Clin Oncol 2010; 28: 1106\u20131111.","DOI":"10.1200\/JCO.2009.25.8475"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39\uff09\u2003Bruner DW, Hunt D, Michalski JM, et al. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the radiation therapy oncology group (RTOG) 0126          prostate cancer trial. Cancer 2015; 121: 2422\u20132430.","DOI":"10.1002\/cncr.29362"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40\uff09\u2003Fischer-Valuck BW, Rao YJ, Michalski JM. Intensity-modulated radiotherapy for prostate cancer. Transl Androl Urol 2018; 7: 297\u2013307.","DOI":"10.21037\/tau.2017.12.16"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41\uff09\u2003Hall WA, Deshmukh S, Bruner DW, et al. Quality of life implications of dose-escalated external beam radiation for localized prostate cancer: results of a prospective randomized phase 3 clinical trial, NRG\/RTOG 0126. Int J Radiat Oncol Biol          Phys 2022; 112: 83\u201392.","DOI":"10.1016\/j.ijrobp.2021.07.004"}],"container-title":["Japanese Journal of Radiological Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jjrt\/81\/4\/81_25-1531\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T03:40:34Z","timestamp":1740800434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jjrt\/81\/4\/81_25-1531\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.6009\/jjrt.25-1531","relation":{},"ISSN":["0369-4305","1881-4883"],"issn-type":[{"type":"print","value":"0369-4305"},{"type":"electronic","value":"1881-4883"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-1531"}}